Once again, I share about HOPE for a cure or therapy for Huntington’s disease. At this time, there is so much HOPE for the many therapies being managed for Huntington’s disease (HD).
I found a great article from the website GoodRxHealth, Huntington’s Disease Medications: What’s New, What’s Now, and What’s Next. Please take time reading it because there are so many promising clinical trials, some trials are close to completion, being conducted in the U.S. and Europe.
I found these two drugs very promising: 
“Pridopidine is an oral investigational drug currently in development for the treatment of Huntington’s disease (HD) . In a recent phase 3 study, people who took pridopidine without other medications experienced benefits related to thinking, behavior, and movement. It is administered in a small, easy-to-swallow capsule twice daily.” This trial is almost complete.
———————————————————————————————————-
“SAGE-718 is a once-daily, oral capsule. It works by targeting the N-methyl-D-aspartate (NMDA) receptor, a protein on nerve cells that’s involved in learning and memory. 
A pair of phase 2 studies are aiming to see if SAGE-718 has beneficial effects on everyday functioning and thinking habits. They’re both scheduled to finish in late 2024. A different phase 3 study, set to be completed in late 2025, is studying its safety and tolerability. What’s more, the FDA recently awarded it an Orphan Drug Designation in October 2023.”
We Can Never Lose HOPE…
I’m a Huntington’s disease (HD) advocate, President of the HDSA San Francisco Bay Area Chapter, a blogger and an author. Visit my website https://theresecrutchermarin.com
1 Comment
Hi honey, nice job!